5-Bromoindole

CAS No. 10075-50-0

5-Bromoindole( —— )

Catalog No. M20866 CAS No. 10075-50-0

5-bromoindole is a potential inhibitor of glycogen synthase kinase 3 (GSK-3)and an important pharmaceutical chemical intermediate.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G 27 In Stock

Biological Information

  • Product Name
    5-Bromoindole
  • Note
    Research use only, not for human use.
  • Brief Description
    5-bromoindole is a potential inhibitor of glycogen synthase kinase 3 (GSK-3)and an important pharmaceutical chemical intermediate.
  • Description
    5-bromoindole is a potential inhibitor of glycogen synthase kinase 3 (GSK-3)and an important pharmaceutical chemical intermediate.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    GSK-3
  • Recptor
    GSK-3
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    10075-50-0
  • Formula Weight
    196.04
  • Molecular Formula
    C8H6BrN
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:39 mg/mL (198.93 mM)
  • SMILES
    Brc1ccc2[nH]ccc2c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Butler-Fernández KM Ramos Z Francis-Malavé AMet al.Synthesis Anti-Cancer and Anti-Migratory Evaluation of 36-Dibromocarbazole and 5-Bromoindole Derivatives.Molecules. 2019 Jul 24;24(15). pii: E2686.
molnova catalog
related products
  • GSK-3β inhibitor 14

    GSK-3β inhibitor 14 (1,5-Benzothiazepin-4(5H)-one, 2,3-dihydro-2-methyl-5-(phenylmethyl)-) is a weak GSK-3β inhibitor, IC50﹥ 100μM.

  • ABC 1183

    ABC1183 is a potent, selective, orally active GSK3α/β and CDK9 inhibitor with IC50 of 327/657 nM and 321 nM (CDK9/cyclin T1).

  • IM-12

    IM-12 is a novel potent GSK-3β inhibitor with IC50 of 53 nM, significantly increases the β-catenin level and activates canonical Wnt signalling.